YES....." BEHOLD THE VOICE OF REASON " ! I give TOB an A+++ for once again articulating how the leadership of a developing Biotech delivers VALUE. This type of VALUE ultimately delivers share price escalation.
TOB, That's your opinion, the PPS tells a different tale. YTD, Down 40 percent on how many press releases? Down 40 percent with the Merck/Cubist deal. Again, logic suggests the reason behind the decline has to be the market they trade on? Leo is gambling the PPS can outweigh the manipulation... So far, he's lost time and possibly a partnership. I don't know any pink-sheet biotechs who have been partnered? Too risky for the large players.
News 
Market Data 
Discover 
AI
